Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
278.40
-1.05 (-0.38%)
At close: May 28, 2025, 4:00 PM
278.16
-0.24 (-0.09%)
After-hours: May 28, 2025, 5:56 PM EDT
Amgen Revenue
Amgen had revenue of $8.15B in the quarter ending March 31, 2025, with 9.43% growth. This brings the company's revenue in the last twelve months to $34.13B, up 15.56% year-over-year. In the year 2024, Amgen had annual revenue of $33.42B with 18.57% growth.
Revenue (ttm)
$34.13B
Revenue Growth
+15.56%
P/S Ratio
4.40
Revenue / Employee
n/a
Employees
n/a
Market Cap
149.70B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 33.42B | 5.23B | 18.57% |
Dec 31, 2023 | 28.19B | 1.87B | 7.09% |
Dec 31, 2022 | 26.32B | 344.00M | 1.32% |
Dec 31, 2021 | 25.98B | 555.00M | 2.18% |
Dec 31, 2020 | 25.42B | 2.06B | 8.83% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
AMGN News
- 19 hours ago - BetterInvesting™ Magazine Update on Stride Inc. (NYSE: LRN) and Amgen Inc. (NASDAQ: AMGN) - PRNewsWire
- 5 days ago - Avoid These Dividend Disasters Before It's Too Late - Seeking Alpha
- 7 days ago - Amgen Inc. (AMGN) RBC Capital Markets Global Healthcare Conference (Transcript) - Seeking Alpha
- 12 days ago - AMGEN TO PRESENT AT THE 2025 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE - PRNewsWire
- 13 days ago - Amgen owes $406 million for monopolizing cholesterol drug market, US jury says - Reuters
- 13 days ago - Stock Of The Day: Amgen Slips With Healthcare Sector, But Signals Point To A Reversal - Benzinga
- 14 days ago - Amgen Inc. (AMGN) BofA Securities 2025 Healthcare Conference (Transcript) - Seeking Alpha
- 16 days ago - Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet - Seeking Alpha